R Oklahoma House · District 30 On the 2026 ballot

Rep. Mark Lawson

Contact Email Phone Official site ↗

Compare

Session

Total votes

9,897

all sessions

Attendance

83%

1,560 missed

Lower than 90% of chamber peers

With party

97%

of cast votes

Higher than 96% of chamber peers

Bipartisan score

2%

crosses aisle rarely

Lower than 97% of chamber peers

Voting record

Yea

8,112

voted in favor

Nay

224

voted against

Absent

1,560

missed votes

Total cast

9,897

across all sessions

Crossed party

185

votes against own party

This page

9,897

matching current filters

Bill

Description

Vote

Result

Tally

Date

HB 3007

Insurance; Cemetery Merchandise Trust Act; definitions; minimum funding requirement; effective date.

Absent

Passed

90–0

Mar 8, 2022

HB 2974

Elections; providing for query of voter registration database; requiring certain notification; requiring investigation; providing exceptions; effective date.

Yea

Passed

66–23

Mar 8, 2022

HB 1792

Disabled persons; terminology; effective date.

Yea

Passed

88–1

Mar 8, 2022

HB 1800

Higher education; tuition status for spouse and dependent children of members of Armed Forces; effective date.

Yea

Passed

85–2

Mar 8, 2022

HB 3564

Teachers; creating the Oklahoma Future Teacher Scholarship and Employment Incentive Program; effective date; emergency.

Yea

Passed

81–5

Mar 8, 2022

HB 3423

Motor vehicles; modifying certain inclusion; modifying allowance fee retention; effective date; emergency; contingent effect.

Yea

Passed

79–3

Mar 8, 2022

HB 3421

Motor vehicles; providing certain payments for motor license agents; effective date; emergency; contingent effect.

Yea

Passed

76–4

Mar 8, 2022

HB 1512

Agriculture; Department of Agriculture, Food and Forestry; power to regulate agriculture structures, equipment and facilities; effective date.

Yea

Passed

80–0

Mar 8, 2022

HB 3087

County jails; officer refusal to receive prisoner; medical exceptions; effective date.

Yea

Passed

91–2

Mar 7, 2022

HB 3414

Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.

Yea

Failed

66–25

Mar 7, 2022